
CAS 1229453-99-9: Acrizanib
Sort by
Found 5 products.
Acrizanib (LHA510)
CAS:Acrizanib is a tyrosine kinase inhibitor that has been shown to reduce the growth of new blood vessels in the eye. Acrizanib inhibits the production of angiogenic growth factors by inhibiting the activity of the VEGF receptor and blocking the binding of VEGF to its receptor. Acrizanib has also been shown to inhibit the activity of other tyrosine kinases, including fibroblast growth factor receptors 1 and 2 (FGFR1 and FGFR2). Acrizanib is administered as an intravitreal injection, which reduces or prevents neovascularization in ocular tissues.Formula:C20H18F3N7O2Purity:Min. 95%Molecular weight:445.4 g/molAcrizanib
CAS:Acrizanib (LHA510) is a VEGFR-2 inhibitor, with an IC50 of 17.4 nM for BaF3-VEGFR-2.Formula:C20H18F3N7O2Purity:98.71% - 98.72%Color and Shape:SolidMolecular weight:445.4Ref: TM-T5373
1mg111.00€5mg274.00€10mg424.00€25mg723.00€50mg1,008.00€100mg1,311.00€1mL*10mM (DMSO)303.00€